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There is no doubt that endovascular aortic aneurysm
repair (EVAR) results in lower perioperative mortality
when compared with open aneurysm repair in elective,
nonruptured, patients. Multiple well-designed, large,
randomized controlled trials (RCTs) have consistently
shown a roughly 50% reduction in the risk of 30-day
mortality in favor of endovascular repair for elective
abdominal aortic aneurysms (AAAs).1e3 Given the
increased mortality associated with open repair of
ruptured AAAs (rAAAs), many surgeons and investigators
expected to see a similar improvement in mortality
when EVAR was compared with open repair (OR) in this
high-risk patient group. The observational literature has
indeed shown such an improvement, with reported
mortality rates following EVAR ranging from 16% to 35%
compared with 37e63% following OR.4e14 This differ-
ence in mortality has been further substantiated by
large administrative database studies,15e17 the largest of
which included data on >42,000 patients and reported areduced in-hospital mortality rate associated with EVAR
in ruptured patients (26% vs. 39%; p < .001).17 With
the sheer volume of observational and administrative
data available indicating a reduction in perioperative
mortality, some authors have argued that randomized
trials comparing EVAR and OR are unnecessary and may
even be unethical.11,18
Many of the beneﬁts touted for EVAR in a patient with a
ruptured AAA seem self-evident: reduced physiologic stress
with avoidance of aortic cross clamping and ischemia-
reperfusion injury, the ability to carry out the procedure
under local anesthetic, reduced hypothermia, and reduced
blood loss. Yet despite these considerations and the weight
of the previous observational data, RCTs to date have
shown no difference in early mortality between EVAR and
OR in ruptured patients. Certainly, these results would seem
surprising to many surgeons; however, one cannot ignore
the evidence.
Two of the trials are smaller, and may be criticized for
being underpowered. The ﬁrst trial, from the UK, included
